Detlev Ganten
Président chez Charité - Universitätsmedizin Berlin
Postes actifs de Detlev Ganten
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin | Président | 01/01/2005 | - |
| Max Planck Institute of Colloids & Interfaces | Président | 01/01/2010 | - |
| GlycoUniverse GmbH & Co KGaA | Directeur/Membre du Conseil | - | - |
Eckert & Ziegler AG
 Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Directeur/Membre du Conseil | - | - |
| World Health Summit | President | 01/01/2009 | - |
| Max Planck Institute of Molecular Plant Physiology | Président | - | - |
Historique de carrière de Detlev Ganten
Anciens postes connus de Detlev Ganten
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ECKERT & ZIEGLER SE | Directeur/Membre du Conseil | 20/05/2009 | 29/05/2019 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | 01/01/1991 | 01/01/2004 |
| Université PSL | Directeur/Membre du Conseil | - | - |
Formation de Detlev Ganten
| McGill University | Doctorate Degree |
| Eberhard Karls Universität Tübingen | Undergraduate Degree |
Statistiques
Internationale
| Allemagne | 10 |
| Canada | 2 |
| France | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chairman | 3 |
| President | 1 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Entreprise privées | 5 |
|---|---|
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Health Services |
| GlycoUniverse GmbH & Co KGaA | |
| World Health Summit | |
| Max Planck Institute of Molecular Plant Physiology |
- Bourse
- Insiders
- Detlev Ganten
- Expérience
